Johnson & Johnson has sold more than $500 million worth of its Covid vaccine in the third quarter as the company reported an impressive Q3 result.
Johnson & Johnson has sold more than $500 million worth of its Covid vaccine in the third quarter as the company reported an impressive Q3 result.



